@Article{Stachowiak2011,
journal="Menopause Review/Przegląd Menopauzalny",
issn="1643-8876",
volume="10",
number="1",
year="2011",
title="Clinical aspects of urogenital atrophy in women",
abstract="Female urogenital atrophy increases with the menopausal age. It is also susceptible to various types of hormonal therapy, e.g. systemic menopausal hormonal therapy and vaginal hormone therapy. Tibolone,   a synthetic steroid with the affinity to all the basic types of steroid receptors – oestrogen, progesterone and androgen, is a good (i.e. effective and safe) alternative option to other therapies of atrophic lesions of the lower urogenital tract in women.",
author="Stachowiak, Grzegorz
and Pertyński, Tomasz",
pages="1--4",
url="https://www.termedia.pl/Clinical-aspects-of-urogenital-atrophy-in-women,4,16337,1,1.html"
}